Compare LITS & FUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITS | FUSE |
|---|---|---|
| Founded | 2000 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 43.2M |
| IPO Year | N/A | N/A |
| Metric | LITS | FUSE |
|---|---|---|
| Price | $1.29 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 610.7K | 56.0K |
| Earning Date | 02-10-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,949,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 6.87 |
| 52 Week Low | $1.26 | $1.45 |
| 52 Week High | $9.00 | $25.00 |
| Indicator | LITS | FUSE |
|---|---|---|
| Relative Strength Index (RSI) | 40.07 | 40.21 |
| Support Level | $1.26 | $1.60 |
| Resistance Level | $1.65 | $1.89 |
| Average True Range (ATR) | 0.09 | 0.18 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 7.69 | 8.16 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.